Skip to Main Content

Paper Details

The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing.
Nat Biotechnol
52
2020
Author NameAffiliation
Matthew MacKayWeill Cornell Medical College
Matthew MacKay
Matthew MacKayThe HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Marc Salit
Feng ZhangHarvard Medical School
Feng ZhangHarvard Medical School
Junbiao DaiShenzhen Institutes of Advanced Technology
Shawn LevyHudsonAlpha Institute for Biotechnology
Shawn LevyHudsonAlpha Institute for Biotechnology
Jeff Huber
Alison J KriegelMedical College of Wisconsin
Anne L WyllieYale School of Public Health
Christopher E MasonWeill Cornell Medical College
Christopher E MasonThe HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Christopher E Mason
Christopher E MasonThe Feil Family Brain and Mind Research Institute
Christopher E MasonWeill Cornell Medical College
Christopher E MasonThe HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Christopher E Mason
Christopher E MasonThe Feil Family Brain and Mind Research Institute
  • 1 - 20

Datasets